You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

toripalimab

Showing 26 - 50 of 139
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Pancreatic Cancer Trial in Shanghai (CT-707, Toripalimab, Gemcitabine)

Recruiting
  • Advanced Pancreatic Cancer
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Oct 17, 2022

Esophageal Cancer, Radiation Therapy, Immunotherapy Trial in Taizhou (Toripalimab, Tegafur, IMRT)

Recruiting
  • Esophageal Cancer
  • +3 more
  • Toripalimab
  • +2 more
  • Taizhou, Zhejiang, China
  • +1 more
Apr 15, 2023

Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Mismatch Repair Deficiency Trial in China

Not yet recruiting
  • Adenocarcinoma of the Stomach
  • +2 more
  • Toripalimab
  • +2 more
  • Hangzhou, Zhejiang, China
  • +7 more
Feb 7, 2023

Stage III NSCLC Trial (Toripalimab, JS004, Pemetrexed)

Not yet recruiting
  • Stage III Non-small Cell Lung Cancer
  • Toripalimab
  • +5 more
  • (no location specified)
Jun 3, 2023

Breast Tumors Trial in Beijing, Nanjing, Changsha (Disitamab Vedotin, Toripalimab)

Not yet recruiting
  • Breast Neoplasms
  • Disitamab Vedotin
  • Toripalimab
  • Beijing, Cancer Hospital Chinese Academy Of Medical Sciences, China
  • +2 more
Oct 23, 2023

Advanced Solid Tumor Trial in Blacktown, Kogarah, Frankston (YH001, Toripalimab)

Completed
  • Advanced Solid Tumor
  • Blacktown, New South Wales, Australia
  • +2 more
Dec 19, 2022

Advanced Lung Cancer Trial in Shanghai (Recombinant humanized anti-BTLA mAb (JS004) injection, Toripalimab, Docetaxel)

Not yet recruiting
  • Advanced Lung Cancer
  • Recombinant humanized anti-BTLA monoclonal antibody (JS004) injection
  • +7 more
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Dec 23, 2022

Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Epstein-Barr Virus-Associated Gastric Carcinoma Trial

Not yet recruiting
  • Adenocarcinoma of the Stomach
  • +2 more
  • Toripalimab
  • +2 more
  • Hangzhou, Zhejiang, China
  • +7 more
Jul 25, 2023

Advanced Solid Tumor Trial in Foshan, Guangzhou, Nanning (APG-1387 for Injection, Toripalimab)

Recruiting
  • Advanced Solid Tumor
  • APG-1387 for Injection
  • Toripalimab
  • Foshan, Guangdong, China
  • +2 more
Oct 18, 2022

Esophageal Squamous Cell Carcinoma Trial in Guangzhou (Toripalimab, Paclitaxel-albumin, Nedaplatin)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Toripalimab
  • +4 more
  • Guangzhou, Guangdong, China
    Sun yat-sen University Cancer Center
Oct 25, 2022

Melanoma Trial in Xi'an (Recombinant human interferon a1b, Toripalimab, Anlotinib HCl)

Not yet recruiting
  • Melanoma
  • Recombinant human interferon α1b
  • +2 more
  • Xi'an, Shaanxi, China
    Air Force Military Medical University/ Fourth Military Medical U
Sep 13, 2022

Hepatocellular Carcinoma Trial (HAIC(FOLFOX), Oxaliplatin, Leucovorin)

Not yet recruiting
  • Hepatocellular Carcinoma
  • HAIC(FOLFOX)
  • +5 more
  • (no location specified)
Aug 16, 2022

Advanced Melanoma Trial in China (LBL-007, Toripalimab, Axitinib Tablets)

Recruiting
  • Advanced Melanoma
  • Beijing, Beijing, China
  • +7 more
Jan 9, 2023

Laryngeal Cancer, Hypopharyngeal Cancer Trial in Shanghai (Toripalimab)

Recruiting
  • Laryngeal Cancer
  • Hypopharyngeal Cancer
  • Toripalimab
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jun 12, 2022

Intrahepatic Cholangiocarcinoma Trial in Shanghai (Toripalimab, Lenvatinib mesylate capsules, Placebo IV)

Not yet recruiting
  • Intrahepatic Cholangiocarcinoma
  • Toripalimab
  • +6 more
  • Shanghai, Shanghai, China
    Zhongshan Hospital affiliated to Fudan University
Aug 12, 2022

NSCLC, RET Driver Mutation, BRAF V600 Mutation Trial in Guanzhou (Toripalimab, Nab paclitaxel, Pemetrexed)

Recruiting
  • Non-Small Cell Lung Cancer
  • +5 more
  • Toripalimab
  • +3 more
  • Guanzhou, Guangdong, China
    Guangdong Lung Cancer Institute, Guangdong Provincial People's H
Apr 4, 2023

Biliary Tract Adenocarcinoma Trial in Shanghai (HAIC, Gemcitabine, Oxaliplatin)

Enrolling by invitation
  • Biliary Tract Adenocarcinoma
  • HAIC
  • +4 more
  • Shanghai, China
    Fudan University Shanghai Cancer Center
May 27, 2022

Esophageal Squamous Cell Carcinoma by AJCC V8 Stage Trial (Radiotherapy, Toripalimab)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma by AJCC V8 Stage
  • Radiotherapy
  • Toripalimab
  • (no location specified)
Mar 17, 2023

Solid Tumor Trial (GFS101A, Toripalimab)

Withdrawn
  • Solid Tumor
  • (no location specified)
May 16, 2022

NSCLC, Stage III Trial in Chengdu (GFH018, Toripalimab, Paclitaxel)

Not yet recruiting
  • NSCLC, Stage III
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
May 23, 2022

Non-clear Renal Cell Carcinoma Trial in Nanjing, Nanning (Toripalimab, Axitinib)

Recruiting
  • Non-clear Renal Cell Carcinoma
  • Nanjing, Jiangsu, China
  • +1 more
Mar 13, 2023

Advanced Solid Tumor Trial in Melbourne (LM-302, Toripalimab)

Enrolling by invitation
  • Advanced Solid Tumor
  • Melbourne, Australia
    The Alfred
May 20, 2022

Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, HER2-positive Gastric Cancer Trial in China

Not yet recruiting
  • Adenocarcinoma of the Stomach
  • +2 more
  • Toripalimab
  • +2 more
  • Hangzhou, Zhejiang, China
  • +7 more
Feb 7, 2023

Locally Advanced Head and Neck Squamous Cell Carcinoma Trial in Tianjin (Toripalimab, Stereotactic Body Radiation Therapy

Not yet recruiting
  • Locally Advanced Head and Neck Squamous Cell Carcinoma
  • Toripalimab
  • Stereotactic Body Radiation Therapy (SBRT)
  • Tianjin, China
  • +1 more
May 16, 2023

Breast Cancer, TNBC - Triple-Negative Breast Cancer Trial (Toripalimab, Epirubicin, High Intensity Focused Ultrasoun)

Not yet recruiting
  • Breast Cancer
  • TNBC - Triple-Negative Breast Cancer
  • Toripalimab
  • +5 more
  • (no location specified)
Aug 5, 2022